Pathophysiology of non-insulin-dependent diabetes and the search for candidate genes: dangerous liaisons?

Barnett AH, Eff C, Leslie RD, Pyke DA, Diabetes in identical twins. A study of 200 pairs. Diabetologia 20:87–93, 1981Google Scholar

Newman B, Selby JV, King MC, Slemenda C, Fabsitz R, Friedman GD, Concordance for type 2 (non-insulin dependent) diabetes mellitus in male twins. Diabetologia 30:763–768, 1987Google Scholar

Kobberling J, Tilli H, Empirical risk figures for the first-degree relatives of non-insulin dependent diabetics. In: Kobberling J, Tattersal R (eds) The genetics of diabetes mellitus. Academic Press, London, pp 201–209, 1982Google Scholar

Rich SS, Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 39:1315–1319, 1990Google Scholar

Zimmet P, Challenges in diabetes epidemiology — from West to rest. Diabetes Care 15:232–252, 1992Google Scholar

Cook JTE, Page RCL, O'Rahilly S, Levy JC, Holman R, Barrow B, Hattersley AT, Shaw AG, Wainscoat JS, Turner RC, Availability of type II diabetic families for detection of diabetes susceptibility genes. Diabetes 42:1536–1543, 1993Google Scholar

McCarty MI, Froguel P, Hitman GA, The genetics of non-insulin-dependent diabetes mellitus: tools and aims. Diabetologia 37:959–968, 1994Google Scholar

Turner RC, Hattersley AT, Shaw JTE, Levy JC, Type II diabetes: clinical aspects of molecular biological studies. Diabetes 44:1–10, 1995Google Scholar

Cook JTE, Hattersley AT, Levy JC, Patel P, Wainscoat JS, Hockaday DR, Turner RC, Distribution of type II diabetes in nuclear families. Diabetes 42:106–112, 1993Google Scholar

Lander ES, Schork NJ, Genetic dissection of complex traits. Science 265:2037–2048, 1994Google Scholar

Risch N, Zhang H, Extreme discordant sib pairs for mapping quantitative trait loci in humans. Science 268:1584–1589, 1995Google Scholar

Ghosh S, Schork NJ, Genetic analysis of NIDDM. Diabetes 45:1–14, 1996Google Scholar

Davies JL, Kawaguchi Y, Bennett ST, Copeman JB, Cordell HJ, Pritchard LE, Reed PW, Gough SCL, Jenkins SC, Palmer SM, Balfour KM, Rowe BR, Farral M, Barnett AH, Bain SC, Todd JA, A genome wide search for human type 1 diabetes susceptibility genes. Nature 371:130–136, 1994Google Scholar

Hashimoto L, Habita C, Beressi JP, Delepine M, Besse C, Cambon-Thomsen A, Deschamps I, Rotter JI, Djoulah S, James MR, Froguel P, Weissenbach J, Lathrop GM, Julier C, Genetic mapping of a susceptibility locus for insulin-dependent diabetes mellitus on chromosome 11q. Nature 371:161–164, 1994Google Scholar

Hanis CI, Boerwinkle E, Chakraborty R, Ellsworth DL, Concannon P, Stirling B, Morrison VA, Wapelhorst B, Spielman RS, Gogolin-Ewens KJ, Shephard JM, Williams SR, Risch N, Hinds D, Iwasaki N, Ogata M, Omori Y, Petzold C, Rietzsch H, Schroder H-E, Schulze J, Cox NJ, Menzel S, Boriraj VV, Chen X, Lim LR, Lindner T, Mereu LE, Wang Y-Q, Xiang K, Yamagata K, Yang Y, Bell GI, A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 13:161–167, 1996Google Scholar

Mahatani MM, Widen E, Letho M, Thomas J, McCarthy M, Brayer J, Bryant B, Chan G, Daly M, Forsblom C, Kanninen T, Kirby A, Kruglyak L, Munnelly K, Parkkonen M, Reeve-Daly MP, Weaver A, Brettin T, Duyk G, Lander ES, Groop LC, Mapping of a gene for type 2 diabetes associated with an insulin secretion defect by genome scan in Finnish families. Nat Genet 14:90–94, 1996Google Scholar

Lander E, Kruglyak L, Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet 11:241–247, 1995Google Scholar

Groop LC, Widen E, Ferrannini E, Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Diabetologia 36:1326–1331, 1993Google Scholar

Cerasi E, Insulin deficiency and insulin resistance in the pathogenesis of NIDDM: is a divorce possible? Diabetologia 38:992–997, 1995Google Scholar

Polonsky KS, Sturis J, Bell GI, Non-insulin-dependent diabetes mellitus — a genetically programmed failure of the beta cell to compensate for insulin resistance. N Engl J Med 334:777–783, 1996Google Scholar

DeFronzo R, The triumvirate: b-cell, muscle, liver. A collusion responsible for NIDDM. Diabetes 37:667–687, 1988Google Scholar

Beck-Nielsen H, Hother-Nielsen O, Vaag A, Alford F, Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: the role of the skeletal muscle glucose uptake and heptic glucose production in the development of hyperglycaemia. A critical comment. Diabetologia 37:217–221, 1994Google Scholar

Reaven GM, The fourth musketeer — from Alexandre Dumas to Claude Bernerd. Diabetologia 38:3–13, 1995Google Scholar

Thornburn AW, Gumbiner B, Bulacan F, Brechtel G, Henry RR, Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus. J Clin Invest 87:489–495, 1991Google Scholar

Well AM, Sutcliffe IC, Johnson AB, Taylor R, Abnormal activation of glycogen synthesis in fibroblasts from NIDDN subjects: evidence for an abnormality specific to glucose metabolism. Diabetes 42:583–589, 1993Google Scholar

Kelley DE, Mandarino LJ, Hyperglycemia normalizes insulinstimulated glucose oxidation and storage in non-insulin dependent diabetes mellitus. J Clin Invest 86:1999–2007, 1990Google Scholar

Bonadonna RC, Del Prato S, Bonora E, Saccomanni MP, Gulli G, Natali A, Frascerra S, Pecori N, Ferrannini E, Bier D, Cobelli C, DeFronzo A, Roles of glucose transport and glucose phosphorylation in muscle insulin resistance of NIDDM. Diabetes 45:915–925, 1996Google Scholar

O'Rahilly SP, Nugent Z, Rudenski AS, Hosker JP, Burnett MA, Darling P, Turner RC, Beta-cell dysfunction, rather than insulin-sensitivity, is the primary defect in familial type 2 diabetes. Lancet 2:360–364, 1986Google Scholar

Lillioja S, Mott DM, Howard BW, Bennet PH, Yki-Jarvinen H, Freymond D, Nyomba BL, Zurlo F, Swinburn B, Bogardus C, Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318:1217–1225, 1988Google Scholar

Eriksson J, Franssila-Kallunki A, Ekstrand A, Saloranta C, Widen E, Schalin C, Groop LC Early metabolic defects in persons at increased risk of non-insulin dependent diabetes mellitus. N Engl J Med 321:337–343, 1989Google Scholar

Martin BC, Warram JH, Krolewski AS, Bergman RN, Soeldner JS, Kahn CR, Role of glucose and insulin resistance in the development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925–929, 1992Google Scholar

Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H, Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690–698, 1995Google Scholar

Gulli G, Ferrannini E, Stern M, Haffner S, De Fronzo RA, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican American NIDDM parents. Diabetes 41:1575–1586, 1992Google Scholar

Vaag A, Henriksen JE, Beck-Nielsen H, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin dependent diabetes mellitus. J Clin Invest 89:782–788, 1992Google Scholar

Schalin-Jantti C, Harkonen M, Groop LC, Impaired activation of glycogen synthase in people at increased risk for developing NIDDM. Diabetes 41:598–604, 1992Google Scholar

Rothman DL, Magnusson I, Cline G, Gerard D, Kahn CR, Shulman RG, Shulman GI, Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci (USA) 92:983–987, 1995Google Scholar

Barbetti F, Raben N, Kadowaki T, Cama A, Accili D, Merenich JH, Gabbay KH, Taylor SI, Roth J, Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: identification of the mutation by direct sequencing of genomic DNA amplified by polymerase chain reaction. J Clin Endocrinol Metab 71:164–169, 1990Google Scholar

Yano H, Kitano N, Morimoto M, Polonsky KS, Imura H, Seino Y, A novel point mutation in the human insulin gene giving rise to hyperproinsulinemia (Proinsulin Kyoto). J Clin Invest 89:1902–1907, 1992Google Scholar

Raben N, Barbetti F, Cama A, Lesniak MA, Lillioja S, Zimmett P, Serjeantson SW, Taylor SI, Roth J, Normal coding sequence of insulin gene in Pima Indians and Naruans, two groups with the highest prevalence of type II diabetes. Diabetes 40:118–122, 1991Google Scholar

Kishimoto M, Sakura H, Hayashi K, Akanuma Y, Yazaki Y, Kasuga M, Kadowaki T, Detection of mutations in the human insulin gene by single stranded conformation polymorphisms. J Clin Endocrinol Metab 74:1027–1031, 1992Google Scholar

Olansky L, Janssen R, Welling C, Permutt MA, Variability of the insulin gene in American Blacks with NIDDM. Analysis by single-strand conformational polymorphisms. Diabetes 41:742–749, 1992Google Scholar

Ohagi S, Sakaguchi H, Sanke T, Tatsuta H, Hanabusa T, Nanjo K, Human prohormone convertase 3 gene. Exon-intron organization and molecular scanning for mutations in Japanese subjects with NIDDM. Diabetes 45:897–901, 1996Google Scholar

Naggert JK, Fricker LD, Varlamov O, Nishima PM, Rouille Y, Steiner DF, Carrol RJ, Paigen BJ, Leiter EH, Hyperproinsulinaemia in obese fat/fat mice associated with a carboxypeptidase E mutation which reduces enzyme activity. Nat Genet 10:135–142, 1995Google Scholar

Velho G, Froguel P, Clement K, Pueyo ME, Rakotoambinina B, Zouali H, Passa P, Cohen D, Robert JJ, Primary pancreatic beta-cell secretory defect caused by mutations in glucokinase gene in kindreds of maturity onset diabetes of the young. Lancet 340:444–448, 1992Google Scholar

Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI, Polonski KS, Halter JB, Abnormal insulin secretion, not resistance, is the genetic primary defect of MODY in the RW pedigree. Diabetes 43:40–46, 1994Google Scholar

Vionnet N, Stoffel M, Takeda J, Yasuda K, Bell GI, Zouali H, Lesage S, Velho G, Iris F, Passa P, Froguel P, Cohen D, Non-sense mutation in the glucokinase gene causes early-onset non-insulin dependent diabetes mellitus. Nature 356:721–722, 1992Google Scholar

Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa Ph, Permutt A, Beckmann JS, Bell GI, Cohen D, Familial hyperglycemia due to mutations in glucokinase. N Engl J Med 328:687–702, 1993Google Scholar

Wajngot A, Alvarsson M, Glaser A, Efendic S, Luthman H, Grill V, Glucose potentiation of arginine-induced insulin secretion is impaired in subjects with glucokinase Glu256Lys mutation. Diabetes 43:1402–1406, 1994Google Scholar

Stoffel M, Patel P, Lo Y-M.D., Hattersley AT, Lucassen AM, Page R, Bell JI, Bell GI, Turner RC, Wainscoat JS, Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet 2:153–156, 1992Google Scholar

Katagiri H, Asano T, Ishiara H, Inukai K, Anai M, Miyazaky J-I, Tsukuda K, Kikuchi M, Yazaky Y, Oka Y, Nonsense mutation of glucokinase gene in late-onset non-insulin dependent diabetes mellitus. Lancet 340:1316–1317, 1993Google Scholar

Shimada F, Makino H, Hashimoto N, Taira M, Seino S, Bell GI, Kanatsuka A, Yoshida S, Type 2 (non-insulin-dependent) diabetes mellitus associated with a mutation of the glucokinase gene in a Japanese family. Diabetologia 36:433–437, 1993Google Scholar

Eto K, Sakura H, Shimokawa K, Kadowaki H, Hagura R, Akanuma Y, Yazaki Y, Kadowaki T, Sequence variation of the glucokinase gene in Japanese subjects with NIDDM. Diabetes 42:1133–1137, 1993Google Scholar

Barbetti F, Valsania P, Bell GI, Micossi P, Screening for mutations in the glucokinase gene in a group of italian non insulin dependent diabetics: preliminary results. J Endocrinol Invest 16 [Suppl 1]: Abstr 27, 1993Google Scholar

Shimokawa K, Sakura H, Otabe S, Eto K, Kadowaki H, Hagura R, Yazaki Y, Akanuma Y, Kadowaki T, Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79:883–886, 1994Google Scholar

Bell GI, Xiang K-S, Newman MV, Wu S-H, Wright LG, Fajans SS, Spielman RS, Cox NJ, Gene for non-insulin-dependent diabetes mellitus (maturity-onset diabetes of the young subtype) is linked to DNA polymorphism on human chromosome 20q. Proc Natl Acad Sci USA 88:1484–1488, 1991Google Scholar

Vaxillaire M, Boccio V, Philippi A, Vigouroux C, Terwilliger J, Passa P, Beckmann JS, Velho G, Lathrop MG, Froguel P, A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 9:418–423, 1995Google Scholar

Thomas PM, Cote GJ, Wohllk N, Haddad B, Mathew PM, Rabl W, Aguilar-Bryan L, Gagel RF, Bryan J, Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 268:426–429, 1995Google Scholar

Stirling B, Cox NJ, Bell GI, Hanis CL, Spielman RS, Concannon P, Linkage studies in NIDDM with markers near the sulphonylurea receptor gene. Diabetologia 38:1479–1481, 1995Google Scholar

Iwasaki N, Kawamura M, Yamagata K, Cox NJ Karibe S, Ohgawara H, Inagaki N, Seino S, Bell GI, Omori Y, Idenitification of microsatellite markers near the human genes encoding the b-cell ATP-sensitive K⁺ channel and linkage studies with NIDDM in Japanese. Diabetes 45:267–269, 1996Google Scholar

Zhang Y, Warren-Perry M, Sakura H, Adelman J, Stoffel M, Bell GI, Ashcroft FM, Turner RC, No evidence for mutations in a putative b-cell ATP-sensitive K⁺ channel subunit in MODY, NIDDM, or GDM. Diabetes 44:597–600, 1995Google Scholar

Nishi M, Bell GI, Steiner DF, Islet amyloid polypetide (amylin): no evidence of an abnormal precursor sequence in 25 type 2 diabetic patients. Diabetologia 33:628–630, 1990Google Scholar

Sakagashira S, Sanke T, Hanabusa T, Shimomura H, Ohagi S, Kumagaye KY, Nakajima K, Nanjo K, Missense mutation of amylin gene (S20G) in Japanese NIDDM patients. Diabetes 45:1279–1281, 1996Google Scholar

Janson J, Soeller WC, Roche PC, Nelson RT, Torchia AJ, Kreutter DK, Butler PC, Spontaneous diabetes mellitus in transgenic mice expressing human islet amyloid peptide. Proc Natl Acad Sci (USA) 93:7283–7288, 1996Google Scholar

Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA, Wallace DC, Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nat Genet 1:11–15, 1992Google Scholar

Kadowaki T, Kadowaki H, Mori Y, Tobe K, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y-i, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaky Y, A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330:962–968, 1994Google Scholar

Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, Sierra MdlL, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E, Moncada VY, Kadowaki H, Kadowaki T, Mutations in the insulin receptor gene. Endocrinol Rev 13:566–595, 1992Google Scholar

O'Rahilly S, Choi W Patel P, Turner RC, Flier JS, Moller DE, Detection of mutations in insulin-receptor gene in NIDDM patients by analysis of single-stranded conformation polymorphisms. Diabetes 40:777–782, 1991Google Scholar

Cocozza S, Porcellini A, Riccardi G, Monticelli A, Condorelli G, Ferrara A, et al, NIDDM associated with mutation in tyrosine kinase domain of insulin receptor gene. Diabetes 41:521–526, 1992Google Scholar

Almind K, Bjorbaek C, Vestergaard H, Hansen T, Echwald S, Pedersen O, Aminoacid polymorphisms of insulin receptor substrate-1 in non-insulin-dependent diabetes mellitus. Lancet 342:828–832, 1993Google Scholar

Hitman GA, Hawrami K, McCarty MI, Viswanathan M, Snehalatha C, Ramachandran O, Tuomilehto J, Tuomilehto-Wolf E, Nissinen A, Pedersen O, Insulin receptor substrate-1 gene mutations in NIDDM: implications for the study of polygenic disease. Diabetologia 38:481–486, 1995Google Scholar

Clausen JO, Hansen T, Bjorbaek C, Echwald SM, Urhammer SA, Rasmussen S, Andersen CB, Hansen L, Almind K, Winther K, Haraldsdottir J, Borch-Johnsen K, Pedersen O, Insulin resistance: interactions between obesity and a common variant of insulin receptor substrate-1. Lancet 346:397–402, 1995Google Scholar

Imai Y, Fusco A, Suzuki Y, Lesniak MA, D'Alfonso R, Sesti G, Bertoli A, Lauro R, Accili D, Taylor SI, Variant sequences of insulin receptor substrate-1 in patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 79: 1655–1658, 1994Google Scholar

Hager J, Zouali H, Velho G, Froguel P, Insulin receptor substrate (IRS-1) gene polymorphisms in French NIDDM families. Lancet 342:1430, 1993Google Scholar

Laasko M, Malkki M, Kakalainen P, Kuusisto J, Deeb SS, Insulin receptor substrate-1 variants in non-insulin-dependent diabetes. J Clin Invest 94:1141–1146, 1994Google Scholar

Shimokawa K, Kadowaki H, Sakura H, Otabe S, Hagura R, Kosaka K, Yazaki Y, Akanuma Y, Kadowaki T, Molecular scanning of the glycogen synthase and insulin receptor substrate-1 genes in Japanese subjects with non-insulin-dependent diabetes mellitus. Biochem Biophys Res Commun 202:463–469, 1994Google Scholar

Barbetti F, Cordera R, Valsania P, Laurino C, Bartolini S, Accili D, Arginine for glycine 972 polymorphism in insulin receptor substrate 1 (IRS-I): influence on glucose tolerance. 76th Annual Meeting of the Endocrine Society, Anaheim, USA, Abstr 602, 1994Google Scholar

Tamemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Kaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S, Insulin resistance and growth retardarion in mice lacking insulin receptor substrate-1. Nature 372:182–186, 1994Google Scholar

Araki E, Lipes MA, Patti M-E, Bruning JC, Haag Burritt III, Johnson RS, Kahn CR, Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 372:186–190, 1994Google Scholar

Kusari J, Verma US, Buse JB, Henry RR, Olefski JM, Analysis of the gene sequences of the insulin receptor and the insulin-sensitive glucose transporter (Glut-4) in patients with common type non-insulin dependent diabetes mellitus. J Clin Invest 88:1323–1330, 1991Google Scholar

Choi W-H, O'Rahilly S, Buse JB, Rees A, Morgan R, Flier JS, Moller DE, Molecular scanning of insulin-responsive glucose transporter (GLUT4) gene in NIDDM subjects. Diabetes 40:1712–1718, 1991Google Scholar

O'Rahilly S, Krook A, Morgan R, Rees A, Flier JS, Moller DE, Insulin receptor and insulin-responsive glucose transporter (GLUT4) mutations and polymorphisms in a Welsh type 2 (non-insulin-dependent) diabetic population. Diabetologia 35:486–489, 1992Google Scholar

Bjorbaek C, Echwald S, Hubricht P, Vestergaard H, Hansen T, Zierath J, Pedersen O, Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM. Diabetes 43:976–983, 1994Google Scholar

Deems RO, Evans JL, Deacon RW, Honer CM, Chu DT, Burki K, Fillers WS, Cohen DK, Young DA, Expression of human GLUT4 in mice results in increased insulin action. Diabetologia 37:1097–1104, 1994Google Scholar

Shepherd PR, Gnudi L, tozzo E, Yang H, Leach F, Kahn BB, Adipose cell hyperplasia and enhanced glucose disposal in transgenic mice overexpressing GLUT4 selectively in adipose tissues. J Biol Chem 268:22243–22246, 1993Google Scholar

Katz BE, Stenbit AE, Hatton K, De Pinho R, Charron MJ, Cardiac and adipose tissue abnormalities but not diabetes in mice deficient in GLUT4. Nature 377:151–155, 1995Google Scholar

Laasko M, Malkki M, Deeb SS, Amino acid substitutions in hexokinase II among patients with NIDDM. Diabetes 44:330–334, 1995Google Scholar

Vidal-Puig A, Printz RL, Stratton IM, Granner DK, Moler DE, Analysis of the hexokinase II gene in subjects with insulin resistance and NIDDM and detection of a Gln¹⁴²→His substitution. Diabetes 44:340–346, 1995Google Scholar

Echwald SM, Bjornbaek C, Hansen T, Clausen JO, Vestergaard H, Zierath JR, Printz RL, Granner DK, Pedersen OF, Identification of four amino acid substitutions in hexokinase II and studies of ralationship to NIDDM, glucose effectiveness and insulin sensitivity. Diabetes 44:347–353, 1995Google Scholar

Laasko M, Malkki M, Kekalainen P, Kuusisto J, Deeb SS, Polymorphisms of the human hexokinase II gene: lack of association with NIDDM and insulin resistance. Diabetologia 38:617–622, 1995Google Scholar

Orho M, Nikula-Ijas P, Schalin-Jantti C, Permutt A, Groop LC, Isolation and characterization of the human muscle glycogen synthase gene. Diabetes 44:1099–1105, 1995Google Scholar

Bjornbaek C, Vik TA, Echwald SM, Yang P-Y, Vestergaard H, Wang JP, Webb GC, Richmond K, Hansen T, Erikson RL, Gabor Miklos GL, Cohen PTW, Pedersen O, Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients. Diabetes 44:90–97, 1995Google Scholar

Chen YH, Hansen L, Chen MX, Bjorbaek C, Vestergaard H, Hansen T, Cohen PTW, Pedersen O, Sequence of the human glycogen associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM. Diabetes 43:1234–1241, 1994Google Scholar

Hansen L, Hansen T, Vestergaard H, Biornbaek C, Echwald SM, Clausen JO, Chen YH, Chen MX, Cohen PTW, Pedersen O, A widespread amino acid polymorphism at codon 905 of the glycogen-associated regulatory subunit of protein phosphatease-1 is associated with insulin resistance and hypersecretion of insulin. Hum Molec Genet 4:1313–1320, 1995Google Scholar

Prochazka M, Mochizuki H, Baier LJ, Cohen PTW, Bogardus C, Molecular and linkage analysis of type-1 protein phosphatase catalytic beta-subunit gene: lack of evidence for its major role in insulin resistance in Pima Indians. Diabetologia 38:461–466, 1995Google Scholar

Alonso MD, Lomako J, Lomako WM, Whelan WJ, A new look at the biogenesis of glycogen. FASEB J 9:1126–1137, 1995Google Scholar

Barbetti F, Rocchi M, Bossolasco M, Cordera R, Sbraccia P, Finelli P, Consalez GG, The human skeletal muscle glycogenin gene: cDNA, tissue expression and chromosomal localization. Biochem Biophys Res Commun 220:72–77, 1996Google Scholar

Barbetti F, Raben N, Lesniak MA, Lillioja S, Zimmet P, Serjeantson S, Roth J, β3-adrenoceptor: candidate gene in type II diabetes is normal in Pimas and Nauruans. Diabetes 40 [Suppl 1]:76A, 1991Google Scholar

Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, Manning B, Strosberg D, Stern M, Raben N, Sorkin JD, Roth J, Shuldiner AR, Time of onset of non-insulin-dependent diabetes melitus and genetic variation in the β3-adrenergic-receptor gene. N Engl J Med 333:343–347, 1995Google Scholar

Widen E, Letho M, Kanninen T, Walston J, Shuldiner AR, Groop LC, Association of a polymorphism in the β3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 333:348–351, 1995Google Scholar

Clement K, Vaisse C, Manning BStJ, Basdevant A, Guy-Grand B, Ruiz J, Silver KD, Shuldiner AR, Froguel P, Strosberg D, Genetic variation in the β3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity. N Engl J Med 333:352–354, 1995Google Scholar

Bruening J, Winnay J, Bonner-Wier S, Accili D, Kahn CR, Creating polygenic models of insulin resistance and NIDDM. J Invest Med 44(3):258A, 1996Google Scholar